S576-1001 Screening compound: 1-(1-benzyl-6-oxo-1,6-dihydropyridazin-4-yl)-N-[4-(4-methyl-1H-1,3-benzodiazol-2-yl)phenyl]pyrrolidine-3-carboxamide

S576-1001 Screening compound: 1-(1-benzyl-6-oxo-1,6-dihydropyridazin-4-yl)-N-[4-(4-methyl-1H-1,3-benzodiazol-2-yl)phenyl]pyrrolidine-3-carboxamide
S576-1001 Screening compound: 1-(1-benzyl-6-oxo-1,6-dihydropyridazin-4-yl)-N-[4-(4-methyl-1H-1,3-benzodiazol-2-yl)phenyl]pyrrolidine-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound S576-1001
1-(1-benzyl-6-oxo-1,6-dihydropyridazin-4-yl)-N-[4-(4-methyl-1H-1,3-benzodiazol-2-yl)phenyl]pyrrolidine-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S576-1001

Molecular Formula

C30H28N6O2 (C30 H28 N6 O2)

Compound Name

1-(1-benzyl-6-oxo-1,6-dihydropyridazin-4-yl)-N-[4-(4-methyl-1H-1,3-benzodiazol-2-yl)phenyl]pyrrolidine-3-carboxamide

IUPAC name

1-(1-benzyl-6-oxo-16-dihydropyridazin-4-yl)-N-[4-(4-methyl-1H-13-benzodiazol-2-yl)phenyl]pyrrolidine-3-carboxamide

SMILES

Cc1cccc2c1nc(-c(cc1)ccc1NC(C(CC1)CN1C(C=NN1Cc3ccccc3)=CC1=O)=O)[nH]2

InChI

InChI=1S/C30H28N6O2/c1-20-6-5-9-26-28(20)34-29(33-26)22-10-12-24(13-11-22)32-30(38)23-14-15-35(19-23)25-16-27(37)36(31-17-25)18-21-7-3-2-4-8-21/h2-13,16-17,23H,14-15,18-19H2,1H3,(H,32,38)(H,33,34)/t23-/m1/s1

InChI Key

YREYCQFURBSCCV-HSZRJFAPSA-N

MDL Number (MFCD)

MFCD31960770

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

504.59

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.337

Distribution Coefficient, logD

4.273

Water Solubility, LogSw

-4.28

Polar Surface Area

75.674

Acid Dissociation Constant (pKa)

10.40

Base Dissociation Constant (pKb)

6.60

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

20.00

S576-1001 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
Therapeutical areas:
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds

References: we are preparing a list of scientific research reports with S576-1001 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S576-1001?
Check Price and Availability of S576-1001, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S576-1001 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S576-1001
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S576-1001
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S576-1001 available by request